1636180-98-7 (tarloxotinib bromide,Tarloxotinib bromide)

Tarloxotinib bromide;Tarloxotinib (bromide);3Y31FJ8K50;(E)-4-((4-((3-Bromo-4-chlorophenyl)amino)pyrido[3,4-d]pyrimidin-6-yl)amino)-N,N-dimethyl-N-((1-methyl-4-nitro-1H-imidazol-5-yl)methyl)-4-oxobut-2-en-1-aminium bromide;Tarloxotinib bromide [INN];SB19190;Q27258198;(2E)-4-((4-(3-Bromo-4-chloroanilino)pyrido(3,4-d)pyrimidin-6-yl)amino)-N,N-dimethyl-N-((1-m;TH-4000;G15962;TH-4000;PR-610;MS-31096;CHEMBL4297662;(2E)-4-((4-(3-Bromo-4-chloroanilino)pyrido(3,4-d)pyrimidin-6-yl)amino)-N,N-dimethyl-N-((1-methyl-4-nitro-1H-imidazol-5-yl)methyl)-4-oxobut-2-en-1-aminium bromide;tarloxotinibi bromidum;SCHEMBL17873943;HY-17632;EX-A4349;UNII-3Y31FJ8K50;SCHEMBL11902818;[(E)-4-[[4-(3-bromo-4-chloroanilino)pyrido[3,4-d]pyrimidin-6-yl]amino]-4-oxobut-2-enyl]-dimethyl-[(3-methyl-5-nitroimidazol-4-yl)methyl]azanium;bromide;bromure de tarloxotinib;BT166496;TARLOXOTINIB BROMIDE [WHO-DD];bromuro de tarloxotinib;CS-0016823;1636180-98-7;AKOS040739933;1636180-98-7 (bromide);1H-Imidazole-5-methanaminium, N-((2E)-4-((4-((3-bromo-4-chlorophenyl)amino)pyrido(3,4-d)pyrimidin-6-yl)amino)-4-oxo-2-buten-1-yl)-N,N,1-trimethyl-4-nitro-, bromide (1:1);

WAKIMVYUBWMMHJ-FXRZFVDSSA-N

1S/C24H23BrClN9O3.BrH/c1-33-14-30-24(34(37)38)20(33)12-35(2,3)8-4-5-22(36)32-21-10-16-19(11-27-21)28-13-29-23(16)31-15-6-7-18(26)17(25)9-15;/h4-7,9-11,13-14H,8,12H2,1-3H3,(H-,27,28,29,31,32,36);1H/b5-4+;

BrC1=C(C=CC(=C1)NC1C2C(=CN=C(C=2)NC(/C=C/C[N+](C)(C)CC2=C([N+](=O)[O-])N=CN2C)=O)N=CN=1)Cl.[Br-]